Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00842751 · ClinicalTrials.gov registry record · Phase 2
Oral T7 Oral Testosterone in Man
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
NCT00842751 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 11 participants.
The verdict
NCT00842751, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to test how the body absorbs and processes new forms of oral testosterone. Information gained during the study may help develop better forms of testosterone therapy in the future.
Interventions
- DRUG First Intervention (7 days)
- OTHER First Washout (7 days)
- DRUG Second Intervention (7 days)
- DRUG Third Intervention (7 days)
- OTHER Second wash-out period
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2009-07 |
| Est. Completion | 2009-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00842751
The ClinicalTrials.gov registry entry for NCT00842751 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which First Intervention (7 days) is the first listed.
NCT00842751 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00842751 about?
NCT00842751 is a clinical study titled "Oral T7 Oral Testosterone in Man". The purpose of this study is to test how the body absorbs and processes new forms of oral testosterone. Information gained during the study may help develop better forms of testosterone therapy in the future.
What is the current status of trial NCT00842751?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2009-07. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00842751?
The interventions under investigation include: First Intervention (7 days) (DRUG), First Washout (7 days) (OTHER), Second Intervention (7 days) (DRUG), Third Intervention (7 days) (DRUG), Second wash-out period (OTHER).
Who is sponsoring clinical trial NCT00842751?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.